[Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
D001778:Blood Coagulation Disorders / Q000150:complications*; D001791:Blood Platelet Disorders / Q000150:complications; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000097:blood*; D005169:Factor VIII; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D010973:Platelet Adhesiveness; D014361:Trypsin Inhibitors / Q000378:metabolism
D007328:Insulin; D014361:Trypsin Inhibitors; D005169:Factor VIII; D005340:Fibrinogen
Rola zaburzeń krzepniecia krwi i fibrynolizy u chorych na cukrzyce w rozwoju zmian chorobowych w naczyniach krwionośnych.